FDA, MERCK AND VIOXX: PUTTING PATIENT SAFETY FIRST? HEARING BEFORE THE COMMITTEE ON FINANCE, UNITED STATES SENATE, ONE HUNDRED EIGHTH...Item #: 72453 Pages: 980 pp. Series: HEIN'S ELECTRONIC DOCUMENTS REPRINT SERIES Subjects: HEALTH & SAFETY, MEDICAL LAW AND JURISPRUDENCE FDA, Merck and Vioxx: Putting Patient Safety First?: HearingBefore the Committee on Finance, United States Senate, OneHundred Eight Congress, Second Session, November 18, 2004.This Senate hearing considers allegations of mismanagementby both the Food and Drug Administration and MerckPharmaceutical Company pertaining to Vioxx, a controversialpainkiller that experienced great success before itsultimate removal from the worldwide market. Vioxx is nowconsidered one of the worst drug disasters in history,calling question to Merck's excellent reputation in thefields of research and development. Please contact us to request purchasing information. |